← Back
$RAPP All transactions

Rapport Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$192K

Shares

5,000

Price

$38

Filed

Sep 10

Insider

Name

Gault Cheryl

Title

Chief Operating Officer

CIK

0001839046

Roles

Officer

Transaction Details

Transaction Date

2025-09-08

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

171,928

Footnotes

These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2024. | 25% of the shares underlying this option vested and became exercisable on August 7, 2024, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Filing Info

Accession No.

0001839046-25-000004

Form Type

4

Issuer CIK

0002012593

Gault Cheryl's History

Date Ticker Type Value
2026-03-30 RAPP $201K
2026-03-30 RAPP $81K
2025-11-26 RAPP M $9K
2025-11-26 RAPP $150K
2025-11-26 RAPP M $0
2025-09-08 RAPP M $9K
2025-09-08 RAPP $192K
2025-09-08 RAPP M $0

Other Insiders at RAPP (90d)

Insider Bought Sold Last
Third Rock Ventures V, L.P. $17.2M 2026-04-17
Gault Cheryl
Chief Operating Officer
$282K 2026-03-30
Yeleswaram Krishnaswamy
Chief Development Officer
$1.8M 2026-04-17